• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES BIFURCATED GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES BIFURCATED GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number SBT1602D
Device Problem Insufficient Information (3190)
Patient Problems Ischemia (1942); Thrombosis (2100); Fungal Infection (2419)
Event Date 11/27/2013
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing records verified that this lot met all pre-release specifications.(b)(4).Further investigation is being conducted and the information will be included in the final report.
 
Event Description
The patient presented with a critical ischemia on the left limb where a gore-tex® bifurcated vascular graft was implanted as an aortobifemoral bypass on (b)(6) 2013.Following the operation, candida albicans infection was treated medically.In (b)(6) 2016, the right leg of the bypass presented a thrombosis which was surgically thrombectomyzed.Also the contralateral leg indicated a thrombosis and the presence of a periprosthetic mass was observed.Therefore, a thrombectomy of the left side of the gore-tex® bifurcated vascular graft was performed and a new bypass, with a pet prosthesis, between the left profunda femoris artery and the left common femoral artery, was sutured to the preexisting aortobifemoral bypass on (b)(6) 2016.On (b)(6) 2016, after about 3 years, the prosthesis was explanted due to a candida albicans infection.The patient was implanted with a new aorto-bifemoral bypass (allograft) and is doing well following the procedure.
 
Manufacturer Narrative
(b)(4).The review of the sterilization records verified that this lot met all pre-release specifications.(b)(4).The gore-tex® bifurcated vascular graft was returned to (b)(4), independent laboratory, for investigation.Submitted in formalin was a bifurcated gore-tex® stretch vascular graft: two fragments, one trunk fragment (segment 1) with a non-gore pet graft attached at the distal end and one leg fragment (segment 2).The scope and results of the investigation were summarized and a report was submitted to w.L.Gore & associates.An explant investigator (ei) at w.L.Gore & associates reviewed the report.The following is a summary of the ei observations: tissue present: yes.Graft fragments have multifocal areas of light tan to yellow fibrous tissue adhered to the albumen and appears to have a portion of native vessel attached to the proximal trunk.Luminal tissue deposition cannot be determined via mode of analysis.From gross images segment 1 has one leg transected approximately 2cm distal to the bifurcation and the remaining leg is anastomosed (blue suture) to the pet graft.White suture fragments are present within the proximal trunk and attached vessel which is likely the aortic anastomosis.Segment 2 has been transected at both poles (one strait, one angled).One blue suture fragment is present at the angle cut pole.Metal surgical instruments were used during the evaluation of the returned specimen, as is evident from the photographs in the report.Request for additional analysis: no.Reason: material disruptions are consistent with surgical instruments used during the explant process.Based on review of the report in conjunction with the conclusion of the (b)(4) investigators, no additional analysis is requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIFURCATED GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6408779
MDR Text Key70061081
Report Number2017233-2017-00128
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K904282
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/27/2017
Device Catalogue NumberSBT1602D
Device Lot Number10852071
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/16/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/28/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient Weight95
-
-